Last10K.com

Accentia Biopharmaceuticals Inc (1310094) SEC Filing 10-K Annual report for the fiscal year ending Sunday, September 30, 2007

Accentia Biopharmaceuticals Inc

CIK: 1310094

View differences made from one year to another to evaluate Accentia Biopharmaceuticals Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Accentia Biopharmaceuticals Inc.

Continue

Assess how Accentia Biopharmaceuticals Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Accentia Biopharmaceuticals Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2007 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

Tools
CIK: 1310094
Form Type: 10-K Annual Report
Accession Number: 0001193125-07-273012
Submitted to the SEC: Fri Dec 28 2007 5:09:54 PM EST
Accepted by the SEC: Fri Dec 28 2007
Period: Sunday, September 30, 2007
Industry: Pharmaceutical Preparations

External Resources:

Bookmark the Permalink:
https://last10k.com/sec-filings/1310094/0001193125-07-273012.htm